

Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, has raised $88 million in Series A financing. Northpond Ventures and Cowen Healthcare Investments led the round.
Source: Press Release
Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, has raised $88 million in Series A financing.
Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, has raised $88 million in Series A financing. Northpond Ventures and Cowen Healthcare Investments led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination